TRIMURTHI LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.94 INR | 0.00% |
|
0.00% | +68.36% |
| 25/06 | Trimurthi Limited announced that it has received INR 18.5 million in funding | CI |
| 11/06 | Trimurthi Limited announced that it expects to receive INR 19 million in funding | CI |
Trimurthi Limited is an India-based company, which is engaged in the business of trading of pharmaceuticals and related products and is into the business of trading of shares and securities. The Company's segments include Pharma Business, Financial Services, Investments, Trading in Shares and Foods. Its services include distribution network for pharmaceutical products, retail pharmacy and marketing. Its products include T-SIF-O, Polyflic XT, Ulcizole-DSR, Auscomin-S, T-SIF 200, ACLO-P, LAMITAB, Oriflox, Treb-DSR, Conplus and Volivia Gold.
Calendar
07/08/2024
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +68.36% | 2.27M | |
| +4.23% | 158B | |
| +17.25% | 154B | |
| +7.11% | 135B | |
| +23.37% | 121B | |
| -10.51% | 34.47B | |
| +10.86% | 25.62B | |
| +22.70% | 20.87B | |
| -16.09% | 18.13B | |
| +46.98% | 16.93B |
- Stock Market
- Equities
- TRIMURTHI6 Stock
- News Trimurthi Limited
- Trimurthi Divests Entire Stake in Curova India
